Gyrotonic Exercise in Lupus Adolescents Who Survived From Intensive Care

September 16, 2026 updated by: Ali Mohamed Ali ismail, Cairo University

lupus adoelscented who recently survive from intenive care unit usually complain postintenive care unit syndrome in addition to stress, fatigue, low life quality, depression, low physical performance, low grip strenght, insomnia, weak cariorepsiratory fitness, and low physical capcity. gryotonic exercise may improve these problems

Study Overview

Detailed Description

forty lupus adoelscented who recently survive from intenive care unit will be divided to 8-week gryotonic exercise group (20 patients) and waitlist group who contained the same number (20 patients)

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Giza Governorate
      • Dokki, Giza Governorate, Egypt, 11432
        • Recruiting
        • Cairo University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • childhood-onset lupus
  • adolescents who survived from intensive care unit
  • adlescents who are in risk of developing pos-tintenive care-unit syndrome (i.e patients who admitted to an intenive care unit for at least four days in last year)

Exclusion Criteria:

  • mental diseases
  • upper or lower limb fractures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group I

twenty lupus adoelscented who recently survive from intenive care unit will be perform 8-week gryotonic exercise

twenty lupus adoelscented who recently survive from intenive care unit will be perform 8-week gryotonic exercise

No Intervention: group II

twenty lupus adoelscented who recently survive from intenive care unit will be act as waitlist group for 8 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total score of post-intensive care-syndrome questioanire-related subscales
Time Frame: it will be assessed after 8 weeks

the total score post-intensive care-syndrome questionaire-related subscales (cognitive, physical, and mental) will be assessed

it will be assessed after 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient health questionnaire
Time Frame: it will be assessed after 8 weeks

it is a questionnaire for depression assessment

it will be assessed after 8 weeks
stress vuilnerability scale
Time Frame: it will be assessed after 8 weeks

it is a questionaire assesing stress level

it will be assessed after 8 weeks
physical score of child health questionaire
Time Frame: it will be assessed after 8 weeks

the parent form of this queationaire will assess physical summary level of participants

it will be assessed after 8 weeks
Child health questionaire -mental summary
Time Frame: it will be assessed after 8 weeks

the parent form of this queationaire will assess mental summary level of participants

it will be assessed after 8 weeks
lupus-related life quality (physical health domain)
Time Frame: it will be assessed after 8 weeks

A questionaire will assess lupus-related physical health

it will be assessed after 8 weeks
lupus-related life quality (fatigue domain)
Time Frame: it will be assessed after 8 weeks

a questionaire that will assess lupus-related fatigue

it will be assessed after 8 weeks
Pitsburrg sleeping quality index
Time Frame: it will be assessed after 8 weeks

the total score of this questionaire that measures sleep quality will be evalauted

it will be assessed after 8 weeks
six minute walk distance
Time Frame: it wil be assessed after 8 weeks

it will assess physcial capacity

it wil be assessed after 8 weeks
Ruffier index
Time Frame: it will be assessed after 8 weeks

it is and index that will measure cardiorespiratory fittness

it will be assessed after 8 weeks
grip stenght
Time Frame: it will be assessed after 8 weeks

it will be assessed for dominant hand

it will be assessed after 8 weeks
Short Physical Performance Battery
Time Frame: It will be assessed after 8 weeks

it is assessment for phsyical performance of patients

It will be assessed after 8 weeks
mental subscale of post-intensive care-syndrome questioanire
Time Frame: It will be measured after 8 weeks

the mental subscale of post-intensive care-syndrome questionaire will be assessed

It will be measured after 8 weeks
cognitive subscale of post-intensive care-syndrome questioanire
Time Frame: It will be measured after 8 weeks

the cogniitve subscale of post-intensive care-syndrome questionaire will be assessed

It will be measured after 8 weeks
Physcial subscale of post-intensive care-syndrome questionaire
Time Frame: It will be measured after 8 weeks

the physical subscale of post-intensive care-syndrome questionaire will be assessed

It will be measured after 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali MA Ismail, lecturer, Department of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 11, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

September 16, 2026

First Submitted That Met QC Criteria

September 16, 2026

First Posted (Actual)

September 22, 2026

Study Record Updates

Last Update Posted (Actual)

September 22, 2026

Last Update Submitted That Met QC Criteria

September 16, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB000-14233-100

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe